Is GSK up or down today?
GSK is down 2.71% today, last at 48.54. This stock moved -2.71% versus the prior close.
GSK · GSK
GSK (GSK) is trading at 48.54, down 2.71% on the session. GSK carries a 14-day RSI of 37, and trades below its 50-day average. Over the past month it is down 8.35%.
Leading the coverage: “HUTCHMED shares jump 17% on US$1.3 billion GSK cancer drug deal - Proactive Investors” (Google News Company, 6d ago). GSK is -2.07% since story.
GSK trades on a trailing P/E of 17.9 and is running 7.41% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
GSK is down 2.71% today, last at 48.54. This stock moved -2.71% versus the prior close.
Leading the coverage: “HUTCHMED shares jump 17% on US$1.3 billion GSK cancer drug deal - Proactive Investors” (Google News Company, 6d ago). GSK is -2.07% since story. Dominant story: Market Chatter: GSK Commences Six-Part Dollar Bond Sale to Help Fund Nuvalent Acquisition (1 source, neutral) RSI is 37 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (124 days) · Drag or scroll left for earlier dates
Market Chatter: GSK Commences Six-Part Dollar Bond Sale to Help Fund Nuvalent Acquisition
GSK (NYSE: GSK) sees profit plunge despite higher Q2 sales and launches a new cost‑saving plan - Stock Titan
Is GSK Stock Gaining Fresh Momentum After Its Oncology Acquisition Move Today? - Kalkine Media
GSK plc (GSK) Stock Analysis: Exploring a 17.41% Potential Upside in the Dynamic Healthcare Sector - DirectorsTalk Interviews
GSK stock gains on Nuvalent oncology deal and steady outlook - AD HOC NEWS